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Neurons and Astrocytes of Human Brain . In *Philippe G. Bittar, *Yves Charnay, tLuc Pellerin, *Constantin Bouras, and tPierre J. Magistretti *Departement de Psychiatrie, Division de Neuropsvchiatrie, IUPG Bel-Air, Universite de Geneve, 5 Geneve, Switzerland; and tLaboratoire de Recherche Neurologique, lnstitut de Physi% gie et Service de Neurologie du CHUV, Faculte de Medecine, Universite de Lausanne, Lausanne, Switzer/and Summary: In vertebrates, the interconversion of lactate and pyruvate is catalyzed by the enzyme lactate dehydrogenase, Two distinct subunits combine to form the five tetrameric iso enzymes ofiactate dehydrogenase, The LDH-5 subunit (muscle type) has higher maximal velocity (V max ) and is present in glycolytic tissues, favoring the formation of lactate from pyru vate, The LDH-l subunit (heart typ ' e) is inhibited by pyruvate and therefore preferentially drives the reaction toward the pro duction of pyruvate, There is mounting evidence indicating that during activation the brain resorts to the transient glycolytic processing of glucose, Indeed, transient lactate formation dur ing physiological stimulation has been shown by I H-magnetic resonance spectroscopy, However, since whole-brain arterio venous studies under basal conditions indicate a virtually com plete oxidation of glucose, the vast proportion, of the lactate transiently formed during activatjon is likely to be oxidized, These in vivo data suggest that lactate may be formed in certain Determination of arteriovenous differences for meta bolic intermediates of the brain have clearly shown that glucose is virtually the exclusive metabolic substrate of the brain and that it is almost entirely oxidized to water and carbon dioxide (Siesjo, 1978) , However, clear re gional differences in glucose utilization exist in register with neuronal activity (Sokoloft: 1981) , Interestingly, during activation of specific neuronal pathways, glucose utilization, as monitored with the 2-deoxyglucose auto radiographic technique, increases in the neuropil, i.e., in cells and oxidized in others, We therefore set out to determine whether the two isoforms of lactate dehydrogenase are local ized to selective cell types in the human brain, We report here the production and characterization of two rat antisera, specific for the LDH-5 and LDH-J subunits of lactate dehydrogenase, respectively, Immunohistochemical, immunodot, and westem blot analyses show that these antisera specifically recognize their homologous antigens, Immunohistochemistry on 10 con trol cases demonstrated a differential cellular distribution be tween both subunits in the hippocampus and occipital cortex: neurons are exclusively stained with the anti-LDHI subunit while astrocytes are stained by both antibodies. These obser vations support the notion of a regulated lactate t1ux between astrocytes and neurons. Key Words: Lactate dehydrogenase-2-Deoxyglucose-Positron emission tomography-Magnetic resonance imaging-Immunohistochemistry-Astrocytes, regions enriched in dendrites, axons, and the astrocytic processes that ensheath synapses, not in the cell body (Kadekaro et a!., 1985) . These observations have raised the possibility that during activation astrocytes could contribute to 2-deoxyglucose uptake and phosphoryla tion, Recently, evidence has been provided in primary cultures of astrocytes and neurons Magis tretti, 1994, Pellerin et aI., 1995) and in noncultured guinea pig retina (Poitry-Yamate and Tsacopoulos, 1992) that support this view. In the guinea pig retina, glucose is taken up during activation by glial cells, which then process it to products of glycolysis such as lactate (Poi try-Yamate et a!., 1995), In primary astrocyte cul tures, application of glutamate, which mimics activation, stimulates glucose utilization and lactate production (Pellerin and Magistretti, 1994) . Stimulation of glucose uptake and phosphorylation by glutamate has recently been confirmed in rat astrocytes (Takahashi et aI., 1995) . In view of these observations, and of the growing evi dence that lactate can be an adequate substrate for neu rons to maintain synaptic activity (Schurr and Rigor, 1988) , we have formulated the hypothesis of a metabolic cellular compartmentation whereby during activation glucose is also taken up by astrocytes, which process it glycolytically to lactate for the use of neurons (Pellerin and Magistretti, 1994) . Indeed, the cytological relation ships of astrocytes strongly support this view: astrocytic end-feet surround virtually all brain capillaries (An driezen, 1893; Cajal, 1909; Peters et aI., 1991) , indicat ing a likely role in the transit of metabolic substrates originating from the circulation, while other astrocyte processes ensheath synapses and possess receptors as well as uptake sites for neurotransmitters (Barres, 1991) . These features make astrocytes ideally geared to modu late uptake of substrates from the circulation and "sense" synaptic activity; in other words, astrocytes are well positioned to couple neuronal activity to energy metabolism (Magistretti et aI., 1995; Tsacopoulos and Magistretti, 1996) .
As lactate emerges as an important energy metabolite for brain cells, it follows that the cellular localization of lactate dehydrogenase (LDH, EC 1.1.1.27), the rate limiting enzyme in lactate fluxes, deserves further atten tion. In vertebrates, the five isoenzymes of LDH are a tetrameric combination of two different polypeptide chains (Markert and Appella, 1961) , the A (muscle or M) subunit that we will call here the LDH-5 subunit, and the B (heart or H) subunit that we will term the LDH-1 subunit. The different catalytic properties of the five iso enzymes of LDH (B4 or LDH-l, B3A or LDH-2, B2A2 or LDH-3, BA3 or LDH-4, and A4 or LDH-5) are in proportion to the ratio of LDH-5 to LDH-1 subunits (Cann et aI., 1962; Dawson et aI., 1964; Bishop et aI., 1972) . Furthermore, the relative distribution of LDH-5 and LDH-l subunits is tissue-specific (Plagemann et a!., 1960; . The LDH-5 isozyme is predominantly found in lactate-producing tissues, while the LDH-l isozyme is active in aerobic tissues (e.g., the heart) (Cahn et aI., 1962; Markert et a!., 1975) . It has been proposed (Cahn et a!., 1962) and generally accepted (Pevzner, 1983 ) that the LDH-l isoform is better de signed to oxidize lactate to pyruvate, while the LDH-5 isoform preferentially converts pyruvate to lactate (Cahn et aI., 1962) .
In view of the foregoing considerations, we have pro duced and characterized specific antibodies against both types of subunits, and we have used them in two regions of the adult human brain to reveal the cellular localiza tion of each subunit.
MATERIALS AND METHODS

Preparation of tissues
The brains of 10 control patients with no history of neuro logic. metabolic, or psychiatric disorders and without histo pathological lesions (Table 1) were obtained at autopsy from the Hospitals of the University of Geneva School of Medicine. Postmortem delays ranged between 3 and 12 h. The use of human tissue for this study was approved by the local ethics committee. The brains were routinely screened for histopatho logical lesions, using conventional histological stains and im munohistochemistry procedures, as described in detail else where (Bouras et aI., 1994) . Some blocks of the hippocampal formation and occipital cortex were immediately frozen with CO2 for biochemical analyses, while others were fixed with 4% paraformaldehyde in 0.1 M phosphate buffered saline (PBS; pH 7.4) for 18 h, then immersed in a solution containing 5% su crose for 48 h, and in 10% sucrose for another 48 h before being stored at -SO°e. For control experiments, rabbit heart and psoas muscle freshly dissected from a rabbit killed with CO2 were frozen or fixed a s described above.
Production and characterization of antisera LDH isoenzymes purified from rabbit muscle (LDH-5) and heart (LDH-l) were purchased from Sigma (Buchs Switzer land). Both products were dialyzed overnight against H20 at 4°C and subsequently stored lyophilized. Four Wistar male rats were used for each immunogen. Two rats received approxi mately 200 I-Lg immunogen per injection, while the other two received approximately 50 I-Lg per injection. At days 0 and 15. subcutaneous injections of immunogens were given in 0.2 or 0.025 ml saline emulsified with the same volume of complete Freund's adjuvant (FA). Three booster injections emulsified with incomplete FA were given intraperitoneally at day 30, 45, and 60. Ten days after the last injection, blood was removed from the tails by puncture, and serum was immediately ex tracted by centrifugation and stored at 4"C in the presence of 0.00 I % sodium azide. A first screening for the presence of antibodies was performed by immunohistochemistry in rabbit muscle and heart sections according to the procedure described below. Rats that produced reactive antisera were anesthetized with Nembutal and completely exsanguinated through the heart. Antisera were stored frozen at -80°e. Immunohistochemistry Sera (1 :200) diluted in PBS, pH 7.4, containing 3% bovine serum albumin (BSA) and 0,1% Triton X-IOO were applied overnight at 4°C on 12-f.1m-thick cryostat sections prepared from rabbit heart and muscle or human hippocampus and oc cipital cortex. Following incubation, sections were rinsed in PBS and allowed to incubate for I h with rabbit anti-rat IgG conjugated to peroxidase (Dako, Zug, Switzerland) at a dilution of 1:400. Immunoreaction products were visualized by expos ing the sections to a solution of 0.02% 3,3' -diaminobenzidine tetrahydrochloride (DAB; Sigma) and 0.005% H202 in PBS for 20 min at 20°e. For comparative purposes, a set of adjacent brain sections were processed with a commercial antibody against the glial fibrillary acid protein (GFAP; rabbit IgG anti GFAP, dilution 1:1000; Sigma).
Western blot analysis
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed according to the method of Laemmli (1970) with slight modifications. Briefly, tissue ex tracts from human hippocampi, rabbit heart, muscle, and brain; and mouse brain were homogenized on ice with diluted sample buffer (see below) and centrifuged at 10,000 g for 20 min. All extracts were heated at 100°C for 5 min, and approximately 5 J.1g of protein were loaded onto the gels. The sample buffers contained 100 mM dithiothreitol in the absence of !3-mercap toethanol. For anti-LDHI, 100 mM iodoacetamide was added to the samples after heating, while for anti-LDH5, 8 M urea was added to the sample buffer and the gels contained 4 M urea. The extracts were then electrophoresed on polyacrylamide gels (12%) and transferred electrophoretically onto a nitrocellulose membrane (Bio-Rad, Glattbrugg, Switzerland). After being blocked with nonfat dry milk (Bio-Rad) and washed in PBS, the nitrocellulose membrane was incubated for 5 h with the polyclonal antibodies anti-LDH5 and anti-LDH] at a dilution of I: 1000. Detection of the bound ,mtibodies was performed as described in the section Immunohistochemistry, above. Mo lecular weight markers were used in all gels (Kaleidoscope Prestained Standards from Bio-Rad).
Immunodot analysis
Immunodots were processed as described by Larsson (1981) , with some modifications (Charnay et aI., 1992) . Brielly, human LDH-I from erythrocytes and LDH-5 from placenta (Sigma), as well as the rabbit LDH-I and LDH-5 immunogens were deposited in decreasing amounts. ranging from 10 f.1g to 50 pg of protein. Samples were dried on a cellulose polyacetate mem brane (Sepraphore I J I, Gelman Sciences Inc .. Ann Arbor. MI. U.S.A.) and fixed for 90 min at SO°C with paraformaldehyde vapors. The membranes were then processed and revealed as described above (antisera dilution 1 :500).
RESULTS
Characterization of the antibodies
Overall. biochemical and immunohistochemical con trols clearly showed that anti-LDH I and anti-LDH5 were specific to the LDH-I and LDH-5 subunits. respectively. It can be seen that paraformaldehyde fixation did not alter immunoreactivity in either case (Figs. J and 2). Moreover, it was observed that preincubation (I h at 37°C) of the anti-LDH I and anti-LDH5 with an excess of their homologous antigens totally abolished the cor responding immunoreactivity visualized in human brain tissue sections (data not shown). The details of the char acterization are given below.
Immunodots. The antisera deposited on spots of LDH-J and LDH-5 from human and rabbit sources showed specific reaction of anti�LDH5 and anti-LDHI with LDH-5 and LDH-l, respectively. Both antisera re acted with their corresponding isoenzymes from both species, although at different dilution thresholds. Thus, in the same conditions, anti-LDHI reacted at the lowest threshold of approximately 360 ng for human LDH-I protein, and 38 ng for rabbit LDH-l. For anti-LDH5, thresholds were 36 ng for human LDH-5 protein, and 8 f,Lg for rabbit LDH-5 protein (data not shown).
immunohistochemistry on rabbit heart and muscle cryostat sections. Figure 1 shows the immunoreactivity of anti-LDH5 and anti-LDHI in rabbit heart and muscle sections prepared and revealed in conditions identical to those used for human brain sections. Immunoreactivity of the anti-LDH5 was intense in rabbit muscle (Fig. lA) and virtually absent in rabbit heart (Fig. IC) . In contrast, anti-LDHI reacted faintly with rabbit muscle (Fig. lB) and strongly with rabbit heart (Fig. lD) . Although the conformation of the fixed LDH in situ is unknown, Fig.  1 shows that tissue preparation for immunohistochemis try did not alter antigenicity.
Western blots. Figure 2 illustrates the complete char acterization of anti-LDH5 and anti-LDHI against a va riety of denatured antigens from different tissues and species. In all cases, both antibodies were specific for the monomeric form of their corresponding subunit, whose molecular weight is 35 kDa for both the LDH-5 and LDH-I monomers. The anti-LDH I reacted only with a 35-kDa band on all brain extracts from three different species. i.e., human, rabbit, and mouse as well as with pure LDH-J from human erythrocytes and rabbit heart. Since the anti-LDH I did not recognize pure LDH-5 sub units purified from human and rabbit tissues, it can be assumed that the 70-kDa bands observed with rabbit muscle and heart extracts are probably a homodimeric LDH-I subunit form that renatured in the course of elec trophoresis; this phenomenon is not observed on extracts from human hippocampi or rabbit and mouse brains. The anti-LDH5 reacted specifically with a 35-kDa band from pure human and rabbit LDH-5, rabbit muscle extracts, as well as from human, rabbit, and mouse cerebral cortical extracts. No cross-reactivity was observed with human and rabbit LDH-I and with rabbit heart extracts.
Immunohistochemistry
The characterized antisera against LDH-I and LDH-5 subunits revealed patterns of immunostaining that were constant in all 10 human brains investigated (Figs. 3-6 ).
Human hipp ocampus. As summarized in Table 2 , the anti-LDH5 immunoreactivity was only observed within astrocytes. Its distribution was usually uniform and ho- A, B) . Conversely, heart tissues exhibited a faint LDH-5 subunit immunoreactivity (C), whereas a strong LDH-1 subunit immunoreactivity was observed in the heart (0). Scale bars, 20 �m. mogenous (Fig. 3C ), but clusters of several astrocytes displaying a particularly intense staining were occasion ally observed. The anti-LDH5 immunoreactivity was most intense in astrocytes localized throughout the oc cipital ( Fig. 6D ) and the hippocampal white matter (not shown, but similar to Fig. 6D ), the alveus, the stratum oriens ( Fig. 4B and F) , and the CA4 (Fig. 4D ). They were less abundant than astrocytes stained with a polyclonal antibody directed against the GFAP on adjacent sections. Unlike the typical astrocytes stained with the anti-LDH5 ( Fig. 6E and F) , some had a granular staining comparable to the granules observed in anti-LDHI immunoreactive neurons (Fig. 5A ). This granular astrocytic staining was principally observed in CA4 ( Fig. 4D ) and stratum mo leculare. In the stratum moleculare, as well as in the stratum radiatum, a lower density of astrocytes stained with the anti-LDH5 was observed; their processes were not as clearly visualized as those of other regions. As trocytes stained with the anti-LDH5 were occasionally J Cereb Blood Flow Metab, Vol. 16, No.6, 1996 observed in the CAl (Table 2) , although the intensity and definition of their staining was considerably weaker in this region. Rarely, varicose fibers stained with the anti LDH5 were observed in the alveus. Their density was low compared to the fibers stained by the anti-LDHI (not shown, but similar to Fig. 5D ). Most remarkably, neu rons were never stained by the anti-LDH5 serum (Fig.  4B , D, and F and Table 2 ).
The anti-LDHI immunoreactivity in the hippocampus is illustrated in Fig. 5 and its distribution summarized in Fig. 3B . Cell bodies were stained (Figs. 4A, C, and E and 5A-D) and varicose fibers could be observed in the al veus (not shown), in the stratum moleculare (black arrow of Fig. 5D ) and stratum radiatum (not shown). Astro cytes were also stained in the gray (solid arrows of Fig.  5A and B ) and the white matter ( Fig. 5E and F) . They were abundant in the alveus and stratum oriens ( Fig. 4A  and E, 5C ). The number of astrocytes stained with the anti-LDHI was generally slightly greater than those stained by the anti-LDH5 and comparable in number with astrocytes stained with a polyclonal antibody di rected against GFAP.
Occipital cortex. Despite a smaller number of samples available (cases HC4, HC9, HC lO), a similar trend could be observed in visual areas 17 and 18. The anti-LDH5 immunoreactivity was still principally observed in astro cytes of the first cortical layer (Fig. 6C ) and white matter (Fig. 6D ). Neurons were essentially unlabeled by the anti-LDH5, although a weak and diffuse staining was very rarely seen in neurons of layers IVc and VI of area 17. Interestingly, the anti-LDH5 background staining was also more intense in these two visual areas.
The anti-LDHI immunoreactivity revealed a pattern similar to that observed in the hippocampus: astrocytes were stained in the white (solid arrow of Fig. 6A ) and gray matter (solid arrow of Fig. 6B ), granules could be observed in virtually all neurons (open arrows of Fig. 6A  and B) , and a few varicose fibers were noted in gray matter (not shown). In area 17, the density of neuronal granules was higher in layers IVc and VI (not shown). Similar immunostaining patterns were observed in area 18, with only a decrease in the background staining of the anti-LDH5 and a uniform anti-LDHI staining density of the neurons throughout all cortical layers.
DISCUSSION
Immunohistochemistry
In this article, we have described the immunohisto chemical distribution of LDH-l and LDH-5 subunits in two regions of the human brain. Previous histochemical studies in the monkey occipital cortex demonstrated that LDH activity was mainly localized in layers IV and pre sumptively in layer VI as well as in astrocytes of the first cortical layer (Friede and Fleming, 1963) . The immuno histochemical distribution patterns observed in the hu- man occipital cortex also indicate a predominant local ization of the anti-LDHI and anti-LDHS immunoreac tivity in these layers, as well as in astrocytes of the first cortical layer. In addition, the anti-LDHS immunoreac-<:
tivity was detected in astrocytes of the occipital white matter, where no LDH activity had been detected (Friede and Fleming, 1963) . Interestingly, layers IV and VI, which appear enriched in LDH immunoreactivity, ex- hibit a higher uptake of deoxyglucose in the visual cortex of the monkey (Kennedy et aI., 1976) .
In hippocampus, a good correlation exists between the distribution patterns of immunoreactivity reported here for the human brain and previous histochemical stainings in the rat and monkey brains. Thus, in monkey, LDH activity was high in the perikarya of pyramidal cells and in the fascia dentata, alveus, stratum oriens, and molecu lare, while it was low in the stratum radiatum (Friede and Fleming, 1963) . Another study reported low LDH activ-ity in the stratum lacunosum-mo1eculare and the outer dentate molecular layer of the rat (Borowsky and Collins, 1989) . These authors also found a maximal LDH activity in the stratum oriens, where LDH-S and LDH-1 subunit immunoreactivity was localized mainly in astrocytes (Figs. 4A, B, E, F, and SB) . Despite a generally good correlation between out observations and previous his tochemical studies, some discrepancies were observed. Thus, high LDH activity was found in regions weakly stained by anti-LDHS and anti-LDH1, such as the stra- a Semiquantitative analysis of astrocytes and neurons immunostained with anti-LDH I and anti-LDH5 poly clonal antibodies in the human hippo campus. The scale of assessment was applied for both neurons and astrocyte counts: -,0; +, 1-10; ++, 11-20; +++, more than 20 cells per field (3.22 x 10 5 f1m 2 ). Results shown are the mean of six different fields per specimen chosen at random. tum radiatum and the inner third of the dentate molecular layer (Borowsky and Collins, 1989) , The neuronal cell bodies of both CA and fascia dentata were not stained histochemically (Borowsky and Collins, 1989) , while showing immunoreactivity for anti-LDHI ( Fig. SA-D) . This latter finding correlates well with observations in monkeys, where a strong activity in the inner third of the stratum moleculare was found and neuronal cell bodies of CA and fascia dentata were stained (Friede and flem ing, 1963) .
Results described in this article are also in agreement with previous electrophoretic analyses indic � ting the pre dominance of LDH-l subunits.in the adult brain of vari ous mammalian species including human (Miura, 1966; Gerhardt-Hansen, 1968 ). In the present study, LDH-l subunits are immunolocalized both in astrocytes and neurons. However, results reported in this article indicate that the LDH-5 subunits appear to be exclusively local ized in astrocytes both in hippocampus and visual areas 17 and 18. Our observations are in agreement with a previous study reporting an enrichment of LDH-5 sub units in selected astrocyte populations of the rat brain (Venkov et aI., 1976) and also in astroblasts cultured from chick embryo brains (Tholey et aI., 1981) .
Biochemical considerations
Pyruvate represents the end point of glycolysis in mammalian cells. One of the determining factors in its subsequent fate is the NADHlNAD + ratio. When this ratio is low, pyruvate is converted preferentially to acetyl coenzyme A by pyruvate dehydrogenase (which is nor mally inhibited by high levels of NADH). Subsequently, it enters the tricarboxylic acid cycle to be oxidized and produce energy through the coupled oxidative phos phorylation. Under conditions of high NADH/NAD + ra tio however, which may occur when glycolysis exceeds the capacity of the tricarboxylic acid cycle, pyruvate is converted to lactate by LDH (Stryer, 1988) . In order to sustain a high glycolytic rate, this reaction, which uses NADH as a cofactor, is essential for the regeneration of NAD + used by the glycolytic enzyme glyceraldehyde phosphate dehydrogenase (Stryer, 1988) .
LDH is therefore at the junction between glycolysis and the tricarboxylic acid cycle. Tissues that display in tense but brief increases in activity generally can sustain high glycolytic rates and produce high amounts of lac tate. This is the case in the fast-twitch fibers in skeletal muscles, which produce and release lactate in the circu lation during activity. Such tissues tend to contain higher proportions of the LDH-S subunit, while others such as the heart, which can utilize lactate as a substrate, are enriched in LDH-l subunit (Plagemann et aI., 1960; Wroblewski et aI., 1960; Cahn et aI., 1962) .
Although the kinetic characteristics of enzymes in vitro do not necessarily correspond to their true activity in vivo, they do set a limit to their activity and are a useful indication of their potential significance. Despite numerous influences (including pH and temperature) and the consequent limitations in comparing the kinetic dif ferences between LDH subunits, two major points can be underlined that remain true throughout several condi tions and species (Gerhardt-Hansen, 1968; Holbrook et aI., 1975) : first, LDH-I has a higher substrate affinity (lower Michaelis constant) than LDH-5; LDH-l maxi mal velocity (V maX> is inferior to that of LDH-S (Nitise wojo and Hultin, 1976) . Second, under physiological conditions, LDH-l is allosterically inhibited by pyruvate to a considerably greater degree than LDH-S (Dawson et aI., 1964; Gerhardt-Hansen, 1968; Bishop et aI., 1972) . Lactate also inhibits LDH-J, but at much higher concen trations than pyruvate (Holbrook et aI., 1975) .
Homozygous deficiencies of both LDH-l and LDH-S subunits, which emphasize the glycolytic nature of the LDH-S subunit, have been reported in humans. Thus the absence of the LDH-S subunit has been linked to exer-tional myopathies with myoglobinuria (Kanno et aI., 1983) . During exercise under ischemic conditions, the LDH-5 subunit-deficient patients clearly show an inabil ity to release lactate in the venous blood, as compared to control patients (Kanno et aI., 1988) . Instead, a pyruvate peak is observed in these patients, indicating that the LDH-5 subunit is necessary in vivo for the production and release of high amounts of lactate and that it cannot be efficiently replaced by the LDH-1 subunit for that purpose.
It has been proposed that the LDH-5 isoenzyme is most often associated with glycolytic tissues because it is better adapted to their requirements, being optimally de signed to process large amounts of substrate (Dawson et aI., 1964) . In contrast, kinetic constraints of the LDH-1 isoenzyme are more compatible with the requirements of oxidative metabolism (Dawson et aI., 1964) , i.e., a high affinity for substrates in a low pyruvate environment, since pyruvate is avidly oxidized via the tricarboxylic acid cycle to face energy demands. In such tissues, in cluding the heart, which maintain low pyruvate concen trations, lactate is not only a substrate for LDH, but it becomes an adequate metabolic fuel. Indeed, after con version into pyruvate facilitated by the characteristics of the LDH-1 subunit, lactate becomes an extremely valu able energy fuel, potentially yielding 18 ATP molecules. It can therefore be reasonably argued that cells express ing high levels of LDH-5 subunits are likely to display high glycolytic rates and have the capacity to produce large amounts of lactate. On the other hand, cells ex pressing high levels of LDH-l subunits in the relative absence of LDH-5 subunits will display a metabolic oxi dative profile with a better capacity to utilize lactate as an energy fuel.
In summary, the enrichment of LDH-5 subunits in astrocytes and the presence of LDH-l subunits in neu rons support the hypothesis of a predominant lactate pro duction in astrocytes and oxidation by neurons after con version of lactate to pyruvate. The predominant immu nolocalization of pyruvate dehydrogenase in neuronal perikarya in the rat (Bagley et aI., 1989) and also in the human hippocampus (manuscript in preparation) are consistent with this view.
Physiological implications
The foregoing immunohistochemical observations and biochemical considerations are consistent with the fact that lactate is the major metabolic substrate released by astrocytes, particularly during situations of high energy demand such as activation (Pellerin and Magistretti, 1994) .
There is increasing evidence from functional brain im aging studies that the brain transiently resorts to glycol ysis to face the metabolic needs linked to activation.
J Cereb Blood Flow Metah. Vol. 16, No.6, 1996 Thus, the combined analysis of blood flow, oxygen con sumption, and glucose utilization by PET has indicated an uncoupling during activation, whereby blood flow and glucose utilization increase in excess of oxygen con sumption (Fox and Raichle, 1986; Fox et aI., 1988) . This observation documents the occurrence of activation induced glycolytic processing of glucose. Further con firming the existence of activation-induced glycolysis are I H-magnetic resonance spectroscopy (MRS) studies in which a lactate peak during physiological activation is observed (Prichard et aI., 199 1; Sappey-Marinier et aI., 1992) . Transient lactate formation during activation has also been demonstrated in rat brain with microdialysis studies (Fellows et aI., 1993) . Given the marked (if not exclusive) enrichment of LDH-5 subunits in astrocytes, this set of converging evidence suggests that the in creased lactate production during activation is due to the glycolytic processing of glucose in astrocytes. Indeed, the observation that glutamate, the main excitatory neu rotransmitter released from activated excitatory termi nals, stimulates glucose uptake (Pellerin and Magistretti, 1994; Takahashi et aI., 1995) and lactate release by as trocytes (Pellerin and Magi stretti , 1994) is consistent with this view. Although the possibility of some lactate losses in the circulation cannot be entirely ruled out un der activated conditions, the presence of LDH-1 subunits in neurons and their processes suggests that conversion of lactate to pyruvate for subsequent oxidation is likely to occur. Indeed, a lactate transfer from glia to neurons has been demonstrated in the guinea pig retina (Poitry Yamate et aI., 1995) . This sequence of events would predict a "recoupling," whereby oxygen consumption should increase, with a short temporal delay after acti vation, and the lactate peak should disappear.
Thus biochemical, immunohistochemical, and func tional brain imaging studies support the existence of an "astrocyte-neuron lactate shuttle" whereby during acti vation, glucose, taken up by astrocytic end-feet sur rounding intraparenchymal capillaries, is processed gly co lytic ally to lactate which is released by astrocytes, pro viding an energy substrate for neurons.
